Sfoglia per AUTORE
DAPAVO P
Collezione ASL Vercelli
Items : 2
Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e838-e841. doi: 10.1111/jdv.18314. Epub 2022 Jun 22.
2022
ASL Biella
ASL Asti
AOU Alessandria
ASL Alessandria
ASL Torino 4
AOU Novara
ASL Vercelli
ASL Biella
ASL Asti
AOU Alessandria
ASL Alessandria
ASL Torino 4
AOU Novara
ASL Vercelli
Ribero S; Dapavo P; Quaglino P; Graziola F; Merlo G; Mocci L; Pella P; Giura MT; Rossotto G; Peila R; Leporati C; Addese C; Baggini G; Aragone MG; Pertusi G; Solaroli C; Licciardello M; Cariti C; Macagno N; Boskovic S; Castelli F; Stroppiana E; Passerini SG; Susca S; Ortoncelli M; Verrone A; Tiberio R; Mastorino L;
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2021 Mar;35(3):693-700. doi: 10.1111/jdv.16931. Epub 2020 Oct 13.
2021
ASL Vercelli
AOU Novara
ASL Vercelli
AOU Novara
Gattoni M; Cusano F; Bardazzi F; Pella P; Loconsole F; Lo Schiavo A; Gisondi P; Argenziano G; Offidani AM; Dastoli S; Tiberio R; Rossi M; Parodi A; Dapavo P; Esposito M; Fargnoli MC; Nacca M; Cannavò SP; Pellegrini C; Costanzo A;